Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), société de biopharmaceutique au stade clinique spécialisée dans le développement de...
Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited...
Repositioning of glenzocimab in the treatment of ST-segment elevation myocardial infarction (STEMI) Receivership proceedings: extension of the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads